Latest News about RNXT
Recent news which mentions RNXT
Stocks That Hit 52-Week Lows On Wednesday
May 11, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
From Benzinga
63 Biggest Movers From Yesterday
March 25, 2022
From Benzinga
34 Stocks Moving In Thursday's Mid-Day Session
March 24, 2022
From Benzinga
58 Biggest Movers From Yesterday
March 24, 2022
From Benzinga
23 Stocks Moving in Friday's Pre-Market Session
February 11, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 05, 2022
From Benzinga
5 Short Squeeze Candidates To Watch: Pioneer Power, NuZee Remain At The Top, Grab Rejoins The Leaderboard
December 06, 2021
From Benzinga
From InvestorPlace
5 Short Squeeze Candidates To Watch: Pioneer Power Tops List Along With Newegg, Nuzee And More
November 29, 2021
From Benzinga
76 Biggest Movers From Yesterday
November 11, 2021
From Benzinga
Mid-Afternoon Market Update: Nasdaq Tumbles 300 Points; PubMatic Shares Gain After Q3 Results
November 10, 2021
From Benzinga
Dear FSR Stock Fans, Mark Your Calendars for an EV Catalyst on Nov. 17
November 10, 2021
From InvestorPlace
RNXT Stock Alert: 5 Things to Know as RenovoRx Soars 100+% Today
November 10, 2021
From InvestorPlace
Mid-Morning Market Update: Markets Edge Lower; US Inflation Rate Increases To 6.2%
November 10, 2021
From Benzinga
From InvestorPlace
30 Stocks Moving in Wednesday's Pre-Market Session
November 10, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2021
October 06, 2021
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
72 Biggest Movers From Yesterday
September 08, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Falls Over 200 Points; RenovoRx Shares Spike Higher
September 07, 2021
From Benzinga
Mid-Day Market Update: Gold Drops 2%; Pliant Therapeutics Shares Jump
September 07, 2021
From Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
September 07, 2021
From Benzinga
CEI Stock Alert: What Investors Are Saying About Camber Energy Today as Shares Soar
September 07, 2021
From InvestorPlace
CLOV Stock: What Investors Are Saying About Clover Health Today as Shares Begin a Run Higher
September 07, 2021
From InvestorPlace
RNXT Stock: The FDA News That Has Biotech Company RenovoRx Rocketing Higher Today
September 07, 2021
Tickers
RNXT
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.